You have no items in your shopping cart.
CDKN2A Antibody
Description
Research Area
Images & Validation
−| Tested Applications | ELISA, IF, IHC-P, WB |
|---|---|
| Reactivity | Human, Mouse, Rat |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Immunogen | Anti-CDKN2A antibody (orb1239282) was raised against a peptide corresponding to 18 amino acids near the amino terminus of human CDKN2A. The immunogen is located within the first 50 amino acids of CDKN2A. |
| Target | CDKN2A |
| Molecular Weight | Predicted: 17 kDa Observed: 17 kDa |
| Purification | CDKN2A Antibody is affinity chromatography purified via peptide column. |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Form/Appearance | Liquid |
| Buffer/Preservatives | CDKN2A Antibody is supplied in PBS containing 0.02% sodium azide. |
| Concentration | 1 mg/mL |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−CDKN2A antibody [orb378211]
ICC, IF, IHC-P, WB
Human, Mouse, Porcine, Rat
Rabbit
Polyclonal
Unconjugated
100 μgCDKN2A/p16-INK4a Rabbit Polyclonal Antibody [orb11201]
IF, IHC-Fr, IHC-P
Porcine
Human
Rabbit
Polyclonal
Unconjugated
50 μl, 100 μl, 200 μlCDKN2A/p16-INK4a Rabbit Polyclonal Antibody [orb608177]
IF, IHC-Fr, IHC-P, WB
Porcine
Human, Mouse, Rat
Rabbit
Polyclonal
Unconjugated
50 μl, 100 μl, 200 μl

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

KO Validation of CDKN2A in 293 Cells. Loading: 10 µg of 293 WT cell lysates or CDKN2A KO cell lysates. Antibodies: CDKN2A, orb1239282 (2 µg/mL) and beta-actin, orb1240312 (1 µg/mL), 1 h incubation at RT in 5% NFDM/TBST. Secondary: Goat Anti-Rabbit IgG HRP conjugate at 1:10000 dilution.

Independent Antibody Validation (IAV) via Protein Expression Profile in Cell Lines. Loading: 15 µg of lysates per lane. Antibodies: CDKN2A orb1239282 (4 µg/mL), CDKN2A orb1255478 (4 µg/mL), and beta-actin (1 µg/mL), overnight incubation at 4°C in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

Recombinant Protein Test. Loading: 15 µg of lysates per lane. Antibodies: CDKN2A orb1239282 (2 µg/mL), overnight incubation at 4°C in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: Human prostate (benign hyperplasia) Lane 2: Human CDKN2A recombinant protein (arrow: monomer and dimer).

Western Blot Validation in Human Cell Lines. Loading: 15 µg of lysates per lane. Antibodies: CDKN2A, orb1239282 (2 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

Western Blot Validation in Human Normal and Cancer Tissue. Loading: 15 µg of lysates per lane. Antibodies CDKN2A orb1239282 (2 µg/mL), overnight incubation at 4°C in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: Human breast, Lane 2: Human lung tumor, Lane 3: Human colon cancer.

Western Blot Validation in Mouse Colon Tissue. Loading: 15 µg of lysates per lane. Antibodies: CDKN2A orb1239282 (A: 1 µg/mL, B: 2 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

Immunofluorescence Validation of CDKN2A in Human A431 Cells. Immunofluorescent analysis of 4% paraformaldehyde-fixed A431 cells labeling CDKN2A with orb1239282 at 20 µg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).

Immunofluorescence Validation of CDKN2A in Human Colon Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed human colon tissue labeling CDKN2A with orb1239282 at 20 µg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).

Immunofluorescence Validation of CDKN2A in Rat Colon Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed Rat Colon Tissue labeling CDKN2A with orb1239282 at 20 µg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red) and DAPI staining (blue).

Immunohistochemistry Validation of CDKN2A in Human Colon Tissue. Immunohistochemical analysis of paraffin-embedded Human Colon Tissue using anti- CDKN2A antibody (orb1239282) at 10 µg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

Immunohistochemistry Validation of CDKN2A in Rat Colon Tissue. Immunohistochemical analysis of paraffin-embedded Rat Colon Tissue using anti- CDKN2A antibody (orb1239282) at 5 µg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.
Documents Download
Request a Document
Protocol Information
CDKN2A Antibody (orb1239282)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review





























